Skip to main navigation menu Skip to main content Skip to site footer

Multiple myeloma associated to secundary Sjögren síndrome : first Colombian case report.

Mieloma múltiple asociado a síndrome de Sjögren secundario : primer reporte de caso colombiano.




Section
Original articles

How to Cite
Multiple myeloma associated to secundary Sjögren síndrome : first Colombian case report.
Rev. colomb. hematol. oncol. [Internet]. 2019 May 1 [cited 2024 Dec. 22];6(1):29-32. Disponible en: https://doi.org/10.51643/22562915.7

Dimensions
PlumX
Andrés Felipe Peña Muñoz
    Mónica Duarte Romero
      Paola Ximena Coral Alvarado

        Andrés Felipe Peña Muñoz,

        Médico-microbiólogo, Universidad de los Andes. Residente de medicina interna, Universidad El Bosque.


        Mónica Duarte Romero,

        Hematóloga, médica institucional, Hospital Universitario Fundación Santa Fe de Bogotá.


        Paola Ximena Coral Alvarado,

        Reumatóloga, médica institucional, Hospital Universitario Fundación Santa Fe de Bogotá.


        The association between multiple myeloma (MM) and Sjögren syndrome (SS) is rarely seen. In the following article we present a case report of a Colombian 68 year old female patient with multiple myeloma IgG lambda and SS that responded well to chemotherapy. Initially the patient arrived in the emergency room with acute chest pain and dry eyes and mouth. During her physical exam the only symptom she experienced was pain in her 5th rib. She had complete blood count with hemoglobin of 8.3 g/dl and 25% hematocrit, an erythrocyte sedimentation rate of 120 mm/h and a creatinine of 2.8 mg/dl. Serum protein electrophoresis demonstrated a monoclonal band in the gamma region, with an immunoelectrophoresis with a monoclonal band IgG lambda. Total immunoglobulin quantification showed an elevated IgG and diminished IgM. In addition she had a beta-2 microglobulin level of 440 nmol/l. Skeletal survey was negative for any lytic bone lesions. Bone Marrow biopsy was positive for 95% bone marrow infiltrate by plasma cells in different stages of maturation. Cytogenetics not available. She was treated with 4 cycles of vincristine, doxorubicin, dexamethasone (VAD regimen). After 5 months follow up she was completely asymptomatic for both MM and SS. Simultaneous presentation of both diseases is extremely rare, and although there is literature with many hypotheses of a common origin for both diseases, there is no clear evidence to this effect. There is a need for further research about the genetic and environmental associations between these two diseases to understand their true etiology.


        Article visits 857 | PDF visits 1191


        1. Terpos E, Angelopoulou MK, Variami E, Meletis JC, Vaiopoulos G. Sjögren’s syndrome associated with multiple myeloma. Ann Hematol. 2000;79(8):449-51.
        2. Sanap RR, Athalye AS, Madon PF, Dhabhar BN, Sute MB, Mahabale AA, et al. Detection of t (14;16)(q32;q22) and monosomy 13 by FISH analysis in a patient with multiple myeloma associated with Sjögren’s syndrome: the first case report from India. Case Rep Genet. 2013;2013:279801.
        3. Rodriguez-Cuartero A, Salas-Galan A. Sjögren’s syndrome and multiple myeloma. Eur J Cancer. 1997;33 (1):167-8.
        4. Ghorbel IB, Khanfir M, Houman MH, Lamloum M, Haouet S, Bellil K, et al. Association d’un syndrome de Gougerot-Sjögren et d’un myélome multiple. La Revue de médecine interne. 2003;24 (2):138-9.
        5. Tazi I, Rachid M, Benchekroun S. Sjögren’s síndrome associated with multiple myeloma. Singapore Med J. 2008;49(8):e215-6.
        6. Kaneko H, Ohkawara Y, Taniguchi K, Matsumoto Y, Nomura K, Horiike S, et al. Simultaneous complication of multiple myeloma with Sjogren syndrome. Asian Pac J Allergy Immunol. 2006;24(4):245-8.
        7. Ota T, Wake A, Eto S, Kobayashi T. Sjogren’s syndrome terminating with muttiple myeloma. Scand J Rheumatol. 1995;24(5):316-8.
        8. Fadilah SA, Cheong SK. Multiple myeloma presenting as Sjogren’s syndrome. Am J Hematol. 1999;61(3):217-8.
        9. Söderberg KC, Jonsson F, Winqvist O, Hagmar L, Feychting M. Autoimmune diseases, asthma and risk of haematological malignancies: a nationwide case-control study in Sweden. Eur J Cancer. 2006;42(17):3028-33.
        10. Isshiki I, Okamoto S, Kakimoto T, Chen CK, Mori T, Yokoyama K,et al. Recurrence of autoimmune disease after autologous peripheral blood stem cell transplantation for multiple myeloma. IntJ Hematol. 2006;84(4):354-8.
        11. Lindqvist EK, Goldin LR, Landgren O, Blimark C, Mellqvist UH, Turesson I, et al. Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study. Blood. 2011;118(24):6284-91.
        12. Tula CJ, Berman L, Alexanian R. Connective tissue disease manifested as multiple myeloma. South Med J. 1984;77(12):1580-1.
        13. Anderson LA, Gadalla S, Morton LM, Landgren O, Pfeiffer R, Warren JL, et al. Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer. 2009;125(2):398-405.
        14. Brown LM, Gridley G, Check D, Landgren O. Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders. Blood. 2008;111(7):3388-94.
        Sistema OJS 3.4.0.7 - Metabiblioteca |